RUTH KREIS-ORKOULAS: Open Payments
NPI 1225388283 · POMPANO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 28 payments from 8 companies in 2025. Trend: 2023 $704 · 2024 $608 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 7 | $225 |
| Teva Pharmaceuticals USA, Inc. | 5 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $168 |
| Braeburn Inc. | 5 | $86 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
Products named: SUBLOCADE, AUSTEDO XR, CAPLYTA, BRIXADI, Auvelity, Qelbree, REXULTI, FANAPT.
Industry payments across FL — which companies pay providers there.
